The United States Food and Drug Administration approved the prostate-specific antigen (PSA) test in 1986 for monitoring the progression of prostate cancer;in 19
Background Immediate intravesical instillation of chemotherapeutic agents after transurethral resection (TUR) of nonmuscle invasive transitional cell bladder ca